U.S. Markets closed

How Much Does Biogen Gain From Its $800 Million Gene Therapy Buyout?

ALLISON GATLIN
How Much Does Biogen Gain From Its $800 Million Gene Therapy Buyout?

Biogen's pending acquisition of gene therapy player Nightstar Therapeutics only offers a "modest pipeline boost," an analyst said Tuesday. Nightstar is working on therapies for eye diseases.